Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs072180076Completed
Open-label, single-arm trial of platelet-rich plasma in Alveolar bone atrophy (ABL) and Maxillary sinus pneumatization (MSP). Primary endpoint: Safety (including the adverse events). Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs072180076.